Vous êtes dans : Accueil > Actualités > À lire, à voir, à écouter > The New York Times : Psychiatry’s Identity Crisis

The New York Times : Psychiatry’s Identity Crisis

le 27 juillet 2015

[The New York Times] American psychiatry is facing a quandary: Despite a vast investment in basic neuroscience research and its rich intellectual promise, we have little to show for it on the treatment front.

With few exceptions, every major class of current psychotropic drugs — antidepressants, antipsychotics, anti-anxiety medications — basically targets the same receptors and neurotransmitters in the brain as did their precursors, which were developed in the 1950s and 1960s.

Sure, the newer drugs are generally safer and more tolerable than the older ones, but they are no more effective.

Source The New York Times